Industry News

      Jacques Banchereau, PhD Appointed as Chief Scientific Officer at Javelin Biotech

      WOBURN, Mass.--(BUSINESS WIRE)--Javelin Biotech, Inc., a leading technology company specializing in human tissue chip platforms for biopharma research, is delighted to...

      Saghmos Therapeutics Announces Collaboration with Duke Clinical Research Institute to Optimize Phase 3 Cardio-Renal Metabolic Study

      GREENWICH, Conn.--(BUSINESS WIRE)--Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced it will partner with the Duke Clinical Research Institute...

      PharmAlliance Announces Acquisition of CHEORS

      MORRISVILLE, N.C.--(BUSINESS WIRE)-- #acquisition--PharmAlliance acquires CHEORS, strengthening its global reach and expanding its launch and commercialization capabilities....

      Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics

      DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company, today announced the anticipated return of three programs from...

      Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor

      WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company utilizing its proprietary structural biology and computational chemistry platform, ReSOLVE™, to...

      Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis

      SAN DIEGO--(BUSINESS WIRE)-- #AlloNK--Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis...

      Recent Articles